These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 8706288)

  • 1. Second trimester screening for Down's syndrome using maternal serum dimeric inhibin A.
    Wallace EM; Swanston IA; McNeilly AS; Ashby JP; Blundell G; Calder AA; Groome NP
    Clin Endocrinol (Oxf); 1996 Jan; 44(1):17-21. PubMed ID: 8706288
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amniotic fluid levels of dimeric inhibins, pro-alpha C inhibin, activin A and follistatin in Down's syndrome.
    Wallace EM; D'Antona D; Shearing C; Evans LW; Thirunavukarasu P; Ashby JP; Shade M; Groome NP
    Clin Endocrinol (Oxf); 1999 May; 50(5):669-73. PubMed ID: 10468934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of maternal serum immunoreactive inhibin as a first trimester marker of Down's syndrome.
    Wallace EM; Harkness LM; Burns S; Liston WA
    Clin Endocrinol (Oxf); 1994 Oct; 41(4):483-6. PubMed ID: 7955459
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Second trimester screening for Down's syndrome using maternal serum dimeric inhibin A.
    Haddow JE; Palomaki GE; Knight GJ; Foster DL; Neveux LM
    J Med Screen; 1998; 5(3):115-9. PubMed ID: 9795869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dimeric inhibin A as a marker for Down's syndrome in early pregnancy.
    Aitken DA; Wallace EM; Crossley JA; Swanston IA; van Pareren Y; van Maarle M; Groome NP; Macri JN; Connor JM
    N Engl J Med; 1996 May; 334(19):1231-6. PubMed ID: 8606718
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of maternal serum dimeric inhibin A as a first-trimester marker of Down's syndrome.
    Wallace EM; Grant VE; Swanston IA; Groome NP
    Prenat Diagn; 1995 Apr; 15(4):359-62. PubMed ID: 7617577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. First and second trimester serum tests with and without first trimester ultrasound tests for Down's syndrome screening.
    Alldred SK; Takwoingi Y; Guo B; Pennant M; Deeks JJ; Neilson JP; Alfirevic Z
    Cochrane Database Syst Rev; 2017 Mar; 3(3):CD012599. PubMed ID: 28295159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Second trimester levels of maternal serum inhibin A, total inhibin, alpha inhibin precursor, and activin in Down's syndrome pregnancy.
    Lambert-Messerlian GM; Canick JA; Palomaki GE; Schneyer AL
    J Med Screen; 1996; 3(2):58-62. PubMed ID: 8849760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Second-trimester maternal serum immunoreactive inhibin as a marker for fetal Down's syndrome.
    Van Lith JM; Pratt JJ; Beekhuis JR; Mantingh A
    Prenat Diagn; 1992 Oct; 12(10):801-6. PubMed ID: 1475248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Second-trimester dimeric inhibin-A in Down's syndrome screening.
    Spencer K; Wallace EM; Ritoe S
    Prenat Diagn; 1996 Dec; 16(12):1101-10. PubMed ID: 8994245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Second trimester maternal dimeric inhibin-A in the multiple-marker screening test for Down's syndrome.
    Renier MA; Vereecken A; Van Herck E; Straetmans D; Ramaekers P; Buytaert P
    Hum Reprod; 1998 Mar; 13(3):744-8. PubMed ID: 9572446
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dimeric inhibin A as a fourth marker for Down's syndrome maternal serum screening in native Japanese women.
    Yoshida K; Kuwabara Y; Tanaka T; Onda T; Kudo R; Yamamoto H; Sato A; Yanagida K; Okai T; Sakai M; Takai Y; Uemura H; Hoshi K; Fukada Y; Aono T; Maeda K; Ogita S; Ishiko O; Murata Y; Kanzaki T; Myrick F; Grier RE
    J Obstet Gynaecol Res; 2000 Jun; 26(3):171-4. PubMed ID: 10932977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical validation of a new dimeric inhibin-A assay suitable for second trimester Down's syndrome screening.
    Knight GJ; Palomaki GE; Neveux LM; Haddow JE; Lambert-Messerlian GM
    J Med Screen; 2001; 8(1):2-7. PubMed ID: 11373844
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Second trimester maternal serum ADAM12 levels in Down's syndrome pregnancies.
    Donalson K; Turner S; Wastell H; Cuckle H
    Prenat Diagn; 2008 Oct; 28(10):904-7. PubMed ID: 18785180
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prenatal screening for Down's syndrome using inhibin-A as a serum marker.
    Wald NJ; Densem JW; George L; Muttukrishna S; Knight PG
    Prenat Diagn; 1996 Feb; 16(2):143-53. PubMed ID: 8650125
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SURUSS in perspective.
    Wald NJ; Rodeck C; Hackshaw AK; Rudnicka A
    Semin Perinatol; 2005 Aug; 29(4):225-35. PubMed ID: 16104673
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amniotic fluid inhibin-A in chromosomally normal and Down's syndrome pregnancies.
    Wallace EM; Crossley JA; Groome NP; Aitken DA
    J Endocrinol; 1997 Jan; 152(1):109-12. PubMed ID: 9014845
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Second trimester serum tests for Down's Syndrome screening.
    Alldred SK; Deeks JJ; Guo B; Neilson JP; Alfirevic Z
    Cochrane Database Syst Rev; 2012 Jun; 2012(6):CD009925. PubMed ID: 22696388
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum screening for Down's syndrome between 8 and 14 weeks of pregnancy. International Prenatal Screening Research Group.
    Wald NJ; George L; Smith D; Densem JW; Petterson K
    Br J Obstet Gynaecol; 1996 May; 103(5):407-12. PubMed ID: 8624312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SURUSS in perspective.
    Wald NJ; Rodeck C; Hackshaw AK; Rudnicka A
    BJOG; 2004 Jun; 111(6):521-31. PubMed ID: 15198778
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.